Clinical trial
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
NCT02855658 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
- Lead sponsor
- China Medical University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 28, 2014
- Completion date
- April 30, 2017
- Enrollment
- 90 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
sjögren's syndrome